[144] Symbotic Inc. SEC Filing

Rhea-AI Filing Summary

Symbotic Inc. (SYM) filed a Form 144 reporting a proposed sale of 220,000 shares of common stock on NASDAQ through Morgan Stanley Smith Barney. The notice lists an aggregate market value of $10,218,516 and indicates 111,314,938 shares outstanding, with an approximate sale date of 08/22/2025. The shares were acquired on 06/07/2022 as founder stock from the issuer and paid for in cash. The filer reports no securities sold in the past three months and affirms they are not aware of any undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine insider sale of founder shares representing a small fraction of outstanding stock, executed through a major broker.

The filing documents a proposed sale of 220,000 common shares (aggregate market value $10,218,516) via Morgan Stanley Smith Barney with an approximate sale date of 08/22/2025. The shares were originally acquired as founder stock on 06/07/2022 and paid in cash. No sales by the filer are reported in the prior three months. Based solely on the information provided, this appears to be a standard Rule 144 notice enabling an insider sale rather than a disclosure of operational or financial developments.

Corporate Governance Expert

TL;DR: The filing is a compliance disclosure; it confirms insider liquidity activity without indicating governance or control changes.

The document confirms the seller's relationship to the issuer via founder stock and includes the seller's attestation about material undisclosed information. The sale is routed through a recognized broker and lists no prior three-month sales, suggesting this filing documents the first reported planned sale in the recent period. There is no information here about any change in board composition, control, or related-party transactions beyond the sale notice itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	220000	10218516.00	111314938	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2022	Founder Stock	Issuer			220000	06/07/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Symbotic's Form 144 report for SYM?

The Form 144 reports a proposed sale of 220,000 common shares on NASDAQ through Morgan Stanley Smith Barney, with aggregate market value $10,218,516 and an approximate sale date of 08/22/2025.

When and how were the shares being sold in the SYM Form 144 acquired?

The shares were acquired on 06/07/2022 as founder stock from the issuer and payment was made in cash on that date.

How many shares of Symbotic are outstanding according to the filing?

The filing lists 111,314,938 shares outstanding.

Has the filer sold any Symbotic securities in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months.

Through which broker will the SYM shares be sold?

The sale is to be executed through Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004) as listed in the filing.

Does the filer assert any undisclosed material information about Symbotic?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.